May 07, 2020 / 08:00AM GMT
Torbjørn Furuseth - Targovax ASA - CFO
Good morning, everyone, and welcome to Targovax' First Quarter Virtual Quarterly Presentation. I am Torbjørn Furuseth, I'm the Chief Financial Officer of Targovax. And today, I also have with me is Ãystein Soug, our Chief Executive Officer; and our new Scientific Officer, Victor Levitsky.
This is the first time we're doing a virtual quarterly presentation, so let's hope the technology is on our side today. 2020 has been a very exciting year for us so far with a lot of events. And we will take you through that. The program today, first, we will give an introduction to Targovax and our activities, then go to the highlights, before we introduce Victor, the new Chief Scientific Officer. And then we will talk a little bit about some new pipeline initiatives, before I round up with financials and the news flow.
At Targovax, we strongly believe in the importance of activating the patient's immune system. And we also clearly see that there's a growing need now in the market and in the treatment of patients for immune activators. And
Q1 2020 Targovax ASA Earnings Call Transcript
May 07, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers